3-Month follow-up | |
---|---|
(1) 78-year-old man, AS, CAD, AFib | Status: free from embolic events TAV: normal function, moderate AR ACP: correct position; sufficient LAA exclusion, no shunt and no thrombus Tx: ASA, clopidogrel and no anticoagulation |
(2) 84-year-old woman, AS, CAD, ASD, AFib | Status: free from embolic events TAV: normal function, moderate AR ACP: correct position; sufficient LAA exclusion, no shunt, no thrombus Tx: ASA, clopidogrel, no anticoagulation |
(3) 84-year-old woman, AS, CAD, PFO, AFib | Status: free from embolic events TEE denied Tx: ASA, clopidogrel, no anticoagulation |
(4) 88-year-old woman, AS, CAD, AFib | Status: died from sudden cardiac death 118 days after Intervention TEE not performed |
(5) 85-year-old woman, AS, AFib | Status: free from embolic events TEE denied Tx: clopidogrel, no anticoagulation |
(6) 83-year-old man, AS, CAD, AFib | Status: free from embolic events TAV: normal function, mild AR ACP: correct position; sufficient LAA exclusion, no shunt, no thrombus Tx: ASA, clopidogrel, no anticoagulation |
(7) 79-year-old man, AS, CAD, AFib | Status: free from embolic events TAV: normal function, mild AR ACP: correct position; sufficient LAA exclusion, no shunt, no thrombus Tx: ASA, clopidogrel, no anticoagulation |
(8) 80-year-old woman, AS, CAD, PFO, AFib | Status: free from embolic events TAV: normal function, mild AR PFO: correct position; no residual shunt, no thrombus ACP: correct position; sufficient LAA exclusion, no shunt, no thrombus Tx: ASA, clopidogrel, no anticoagulation |
(9) 63-year-old man, AS, CAD, AFib | Status: free from embolic events TAV: normal function, no AR ACP: correct position; sufficient LAA exclusion, no shunt, no thrombus Tx: ASA, clopidogrel, no anticoagulation |
(10) 89-year-old woman, AS, CAD, AFib | Status: free from embolic events TAV: normal function, no AR ACP: correct position; sufficient LAA exclusion, no shunt, no thrombus Tx: ASA, clopidogrel, no anticoagulation |
ACP, Amplatzer cardiac plug; AS, aortic valve stenosis; ASA, acetylsalicylic acid; AFib, atrial fibrillation; CAD, coronary artery disease; LAA, left atrial appendage; PFO, patent foramen ovale; TAV, transcatheter aortic valve; TEE, transesophageal echocardiography.